MUFG Securities EMEA plc Invests $9.79 Million in Humana Inc. (NYSE:HUM)

Key Points

• MUFG Securities EMEA plc acquired 36,999 shares of Humana Inc., valued at approximately <$9.8 million>, during the first quarter.
• Humana's shares opened at $266.65, with a market cap of $32.07 billion and earnings per share of $6.27, missing estimates by 5 cents.
• Seventeen research analysts have rated Humana with a consensus rating of "Hold" and a price target averaging $281.62.

MUFG Securities EMEA plc acquired a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 36,999 shares of the insurance provider's stock, valued at approximately $9,790,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its holdings in shares of Humana by 8.9% in the 1st quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock valued at $3,697,222,000 after purchasing an additional 1,143,662 shares in the last quarter. Dodge & Cox raised its holdings in shares of Humana by 106.7% in the 4th quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after purchasing an additional 5,264,045 shares in the last quarter. Pzena Investment Management LLC raised its holdings in shares of Humana by 6.1% in the 1st quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider's stock valued at $1,013,133,000 after purchasing an additional 219,541 shares in the last quarter. Davis Selected Advisers raised its holdings in shares of Humana by 3.3% in the 1st quarter. Davis Selected Advisers now owns 2,331,343 shares of the insurance provider's stock valued at $616,873,000 after purchasing an additional 74,434 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. grew its position in shares of Humana by 11.1% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 1,605,771 shares of the insurance provider's stock worth $407,401,000 after buying an additional 160,952 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on HUM shares. Wells Fargo & Company set a $348.00 price objective on shares of Humana in a research report on Friday, July 18th. Bank of America cut their price objective on shares of Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a research report on Tuesday, June 17th. Truist Financial cut their price objective on shares of Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a research report on Wednesday, July 16th. Morgan Stanley cut their price objective on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a research report on Thursday, July 31st. Finally, Robert W. Baird cut their price objective on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research report on Friday, July 25th. Seventeen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $281.62.

Humana Stock Performance

Shares of Humana stock traded up $8.50 on Tuesday, reaching $275.17. The stock had a trading volume of 1,547,126 shares, compared to its average volume of 1,738,603. The business's 50-day moving average price is $238.61 and its two-hundred day moving average price is $253.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $382.72. The stock has a market cap of $33.09 billion, a P/E ratio of 21.12, a price-to-earnings-growth ratio of 1.57 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%. The firm's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the previous year, the company posted $6.96 EPS. On average, sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.